193 related articles for article (PubMed ID: 33390658)
1. Experimental evaluation of
Kim S; Oh T; Yang S; Cho H; Chae C
Can J Vet Res; 2021 Jan; 85(1):77-81. PubMed ID: 33390658
[TBL] [Abstract][Full Text] [Related]
2. Interaction between single-dose Mycoplasma hyopneumoniae and porcine reproductive and respiratory syndrome virus vaccines on dually infected pigs.
Park SJ; Seo HW; Park C; Chae C
Res Vet Sci; 2014 Jun; 96(3):516-22. PubMed ID: 24702900
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of local and systemic immune responses induced by intramuscular injection of a Mycoplasma hyopneumoniae bacterin to pigs.
Thacker EL; Thacker BJ; Kuhn M; Hawkins PA; Waters WR
Am J Vet Res; 2000 Nov; 61(11):1384-9. PubMed ID: 11108184
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of recombinant Mycoplasma hyopneumoniae P97/P102 paralogs formulated with selected adjuvants as vaccines against mycoplasmal pneumonia in pigs.
Woolley LK; Fell SA; Gonsalves JR; Raymond BB; Collins D; Kuit TA; Walker MJ; Djordjevic SP; Eamens GJ; Jenkins C
Vaccine; 2014 Jul; 32(34):4333-41. PubMed ID: 24930717
[TBL] [Abstract][Full Text] [Related]
5. Efficacy comparison of commercial porcine circovirus type 2 (PCV2) and
Yang S; Park SJ; Oh T; Cho H; Chae C
Can J Vet Res; 2020 Oct; 84(4):272-282. PubMed ID: 33012976
[TBL] [Abstract][Full Text] [Related]
6. Interaction of porcine circovirus type 2 and Mycoplasma hyopneumoniae vaccines on dually infected pigs.
Seo HW; Park SJ; Park C; Chae C
Vaccine; 2014 May; 32(21):2480-6. PubMed ID: 24631087
[TBL] [Abstract][Full Text] [Related]
7. A new single-dose bivalent vaccine of porcine circovirus type 2 and Mycoplasma hyopneumoniae elicits protective immunity and improves growth performance under field conditions.
Jeong J; Park C; Choi K; Chae C
Vet Microbiol; 2016 Jan; 182():178-86. PubMed ID: 26711046
[TBL] [Abstract][Full Text] [Related]
8. Effect of challenge of pigs previously immunised with inactivated vaccines containing homologous and heterologous Mycoplasma hyopneumoniae strains.
Villarreal I; Vranckx K; Calus D; Pasmans F; Haesebrouck F; Maes D
BMC Vet Res; 2012 Jan; 8():2. PubMed ID: 22225838
[TBL] [Abstract][Full Text] [Related]
9. Systemic and local immune response in pigs intradermally and intramuscularly injected with inactivated Mycoplasma hyopneumoniae vaccines.
Martelli P; Saleri R; Cavalli V; De Angelis E; Ferrari L; Benetti M; Ferrarini G; Merialdi G; Borghetti P
Vet Microbiol; 2014 Jan; 168(2-4):357-64. PubMed ID: 24332702
[TBL] [Abstract][Full Text] [Related]
10. Comparative efficacy of two single-dose bacterins in the control of Mycoplasma hyopneumoniae in swine raised under commercial conditions in Brazil.
Baccaro MR; Hirose F; Umehara O; Gonçalves LC; Doto DS; Paixão R; Shinya LT; Moreno AM
Vet J; 2006 Nov; 172(3):526-31. PubMed ID: 16129636
[TBL] [Abstract][Full Text] [Related]
11. Experimental efficacy of a trivalent vaccine containing porcine circovirus types 2a/b (PCV2a/b) and Mycoplasma hyopneumoniae against PCV2d and M. hyopneumoniae challenges.
Yang S; Oh T; Park KH; Cho H; Suh J; Chae C
Vet Microbiol; 2021 Jul; 258():109100. PubMed ID: 33984792
[TBL] [Abstract][Full Text] [Related]
12. Potential use of a recombinant replication-defective adenovirus vector carrying the C-terminal portion of the P97 adhesin protein as a vaccine against Mycoplasma hyopneumoniae in swine.
Okamba FR; Arella M; Music N; Jia JJ; Gottschalk M; Gagnon CA
Vaccine; 2010 Jul; 28(30):4802-9. PubMed ID: 20472025
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of one dose vaccination against experimental infection with two Mycoplasma hyopneumoniae strains.
Michiels A; Arsenakis I; Boyen F; Krejci R; Haesebrouck F; Maes D
BMC Vet Res; 2017 Aug; 13(1):274. PubMed ID: 28851359
[TBL] [Abstract][Full Text] [Related]
14. Comparison of 3 vaccination strategies against porcine reproductive and respiratory syndrome virus,
Jeong J; Kang I; Kim S; Park KH; Park C; Chae C
Can J Vet Res; 2018 Jan; 82(1):39-47. PubMed ID: 29382967
[TBL] [Abstract][Full Text] [Related]
15. Serum and mucosal antibody responses and protection in pigs vaccinated against Mycoplasma hyopneumoniae with vaccines containing a denatured membrane antigen pool and adjuvant.
Djordjevic SP; Eamens GJ; Romalis LF; Nicholls PJ; Taylor V; Chin J
Aust Vet J; 1997 Jul; 75(7):504-11. PubMed ID: 9258425
[TBL] [Abstract][Full Text] [Related]
16. Immune responses of a chimaeric protein vaccine containing Mycoplasma hyopneumoniae antigens and LTB against experimental M. hyopneumoniae infection in pigs.
Marchioro SB; Sácristan Rdel P; Michiels A; Haesebrouck F; Conceição FR; Dellagostin OA; Maes D
Vaccine; 2014 Aug; 32(36):4689-94. PubMed ID: 24909331
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of a new bivalent vaccine of porcine circovirus type 2 and Mycoplasma hyopneumoniae (Fostera™ PCV MH) under experimental conditions.
Park C; Jeong J; Choi K; Chae C
Vaccine; 2016 Jan; 34(2):270-275. PubMed ID: 26626212
[TBL] [Abstract][Full Text] [Related]
18. Reduced lung lesions in pigs challenged 25 weeks after the administration of a single dose of Mycoplasma hyopneumoniae vaccine at approximately 1 week of age.
Reynolds SC; St Aubin LB; Sabbadini LG; Kula J; Vogelaar J; Runnels P; Peters AR
Vet J; 2009 Sep; 181(3):312-20. PubMed ID: 18554964
[TBL] [Abstract][Full Text] [Related]
19. Antibody response to Mycoplasma hyopneumoniae infection in vaccinated pigs with or without maternal antibodies induced by sow vaccination.
Martelli P; Terreni M; Guazzetti S; Cavirani S
J Vet Med B Infect Dis Vet Public Health; 2006 Jun; 53(5):229-33. PubMed ID: 16732881
[TBL] [Abstract][Full Text] [Related]
20. An experimental model to evaluate Mycoplasma hyopneumoniae transmission from asymptomatic carriers to unvaccinated and vaccinated sentinel pigs.
Pieters M; Fano E; Pijoan C; Dee S
Can J Vet Res; 2010 Apr; 74(2):157-60. PubMed ID: 20592848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
